<i>Conclusions:</i> These findings underscore the potential of GLP-1 RAs in mitigating atherosclerosis progression and plaque vulnerability, thus enhancing cardiovascular outcomes in individuals with type 2 diabetes mellitus. This evidence concerns the gene GLP1R and atherosclerosis.